会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 1. 发明授权
    • Method for measurement of tissue factor in high sensitivity and
measurement kit therefor
    • 高灵敏度组织因子测量方法及其测量套件
    • US5403716A
    • 1995-04-04
    • US924030
    • 1992-09-03
    • Kimihiko MatsuzawaRyoichi Hasegawa
    • Kimihiko MatsuzawaRyoichi Hasegawa
    • C07K16/36G01N33/86G01N33/544G01N33/535G01N33/551G01N33/577
    • C07K16/36G01N33/86G01N2333/7454Y10S435/81Y10S436/826
    • The present invention provides an improved buffer solution for conducting an immunological method for measuring apoprotein of human tissue factor, and a kit therefor. More specifically, in a method for immunologically measuring the presence or concentration of apoprotein of human tissue factor contained in a sample, which method includes the steps of (1) forming in a buffer solution a ternary complex of (a) a first monoclonal antibody which is capable of specifically binding to the apoprotein and is immobilized on a solid carrier insoluble in the buffer solution, (b) the apoprotein and (c) a labeled second monoclonal antibody which is capable of specifically binding to the apoprotein at a different site from the binding site of the first monoclonal antibody, and (2) measuring the amount of labeled second monoclonal antibody in the ternary complex to determine the presence or concentration of apoprotein in the sample, the improvement of this invention comprising employing a buffer solution(i) containing in a concentration of 2 to 15 weight % at least one nonionic surfactant having an HLB value within a range of 12 to 30, and(ii) containing a protein having a molecular weight of about 16,000 to about 50,000 and an isoelectric point of 1.0 to 5.0.
    • PCT No.PCT / JP92 / 00005 Sec。 371日期:1992年9月3日 102(e)1992年9月3日PCT PCT 1992年1月8日PCT公布。 出版物WO92 / 日本1992年7月23日。本发明提供了一种改进的缓冲溶液,用于进行用于测量人组织因子的脱蛋白的免疫学方法及其试剂盒。 更具体地,在用于免疫测定样品中包含的人组织因子的脱辅基蛋白的存在或浓度的方法中,所述方法包括以下步骤:(1)在缓冲溶液中形成(a)第一单克隆抗体的三元配合物,所述第一单克隆抗体 能够特异性结合载脂蛋白并固定在不溶于缓冲溶液的固体载体上,(b)载脂蛋白和(c)标记的第二单克隆抗体,其能够与不同部位的脱辅基蛋白特异性结合 第一单克隆抗体的结合位点,和(2)测量三元复合物中标记的第二单克隆抗体的量以确定样品中脱辅基蛋白的存在或浓度,本发明的改进包括使用缓冲溶液(i) 浓度为2至15重量%的至少一种HLB值在12至30范围内的非离子表面活性剂,和(ii)含有蛋白质 n的分子量为约16,000至约50,000,等电点为1.0至5.0。
    • 2. 发明授权
    • Novel immunoglobulin derivatives and process for the preparation thereof
    • 新型免疫球蛋白衍生物及其制备方法
    • US4059571A
    • 1977-11-22
    • US555132
    • 1975-03-04
    • Katsuhiko TomibeYasuhiko MasuhoKimihiko MatsuzawaSachio IshimotoKazuo SatakeTsuneo Watanabe
    • Katsuhiko TomibeYasuhiko MasuhoKimihiko MatsuzawaSachio IshimotoKazuo SatakeTsuneo Watanabe
    • C07K16/06A23J1/06
    • C07K16/065
    • Novel immunoglobulin derivatives which are characterized in that in which the interchain disulfide bonds of immunoglobulin are predominantly cleaved, on the average 3 to 5 of the interchain disulfide bonds or the inter- and intra-chain disulfide bonds being cleaved, and so produced sulfur atoms (S-) are S-sulfonated (--S-SO.sub.3). The above immunoglobulin derivatives are prepared by reacting native immunoglobulin withA. a compound capable of forming tetrathionate ion, andB. a compound capable of forming in water, sulfite ion whereby cleaving on the average 3 to 5 inter-chain disulfide bonds, or inter- and intra-chain disulfide bonds, of the native immunoglobulin, and S-sulfonating (S-SO.sub.3) the so formed sulfur atoms. This invention also provides a water-soluble composition for injection containing said immunoglobulin derivative having the titre of anti-diphtheria of at least 1.0 I.U./ml at its concentration of 10.0% by weight, and a pharmaceutically-acceptable solubilizing agent for said immunoglobulin derivative.
    • 新型免疫球蛋白衍生物,其特征在于其中免疫球蛋白的链间二硫键主要被切割,平均3至5个链间二硫键或链内和链内二硫键被切割,并因此产生硫原子( S-)是S-磺化的(-S-SO 3)。 上述免疫球蛋白衍生物通过使天然免疫球蛋白与A.能够形成四硫酸根离子的化合物反应制备,和B.能够在水中形成的化合物,亚硫酸根离子,其中以平均3至5个链间二硫键切割, - 和链内二硫键,以及S-磺化(S-SO 3)如此形成的硫原子。 本发明还提供一种含有所述免疫球蛋白衍生物的水溶性组合物,所述组合物的浓度为10.0重量%时具有至少1.0I./ml至少为1.0I./ml的滴度,以及用于所述免疫球蛋白衍生物的药学上可接受的增溶剂。